Jaume Martorell

TL;DR: The results show that a cellular, tissue-engineered airway with mechanical properties that allow normal functioning, and which is free from the risks of rejection, is produced, suggesting that autologous cells combined with appropriate biomaterials might provide successful treatment for patients with serious clinical disorders.

TL;DR: It is suggested that the seeding of both epithelial and mesenchymal stem cell-derived chondrocytes is necessary for optimal graft survival, and the clinical potential of autologous cell- and tissue-engineered tracheal grafts is confirmed.

TL;DR: There was no development of anti-pig leukocyte antigen antibodies or increase in both IgM and IgG content in mice implanted with bioengineered tracheas and this method holds great promise for the future of tissue-engineered airway replacement.

TL;DR: Subclinical rejection in early protocol biopsies is associated with late appearance of chronic humoral rejection and interstitial fibrosis and tubular atrophy in renal transplants with a protocol biopsy performed within the first 6 months posttransplant between 1988 and 2006.

TL;DR: Assessing donor-specific mBC frequencies may be relevant to better refine patient alloimmune-risk stratification, and provides new insight into the mechanisms of the adaptive humoral allo immune response taking place in kidney transplantation.